JP2019501638A - ニコチンアミドリボシドの微生物生産 - Google Patents

ニコチンアミドリボシドの微生物生産 Download PDF

Info

Publication number
JP2019501638A
JP2019501638A JP2018523761A JP2018523761A JP2019501638A JP 2019501638 A JP2019501638 A JP 2019501638A JP 2018523761 A JP2018523761 A JP 2018523761A JP 2018523761 A JP2018523761 A JP 2018523761A JP 2019501638 A JP2019501638 A JP 2019501638A
Authority
JP
Japan
Prior art keywords
activity
protein
polypeptide
seq
nicotinamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018523761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019501638A5 (enExample
Inventor
アダム ジー． ローレンス，
アダム ジー． ローレンス，
セリーヌ ヴィアルージュ，
セリーヌ ヴィアルージュ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2019501638A publication Critical patent/JP2019501638A/ja
Publication of JP2019501638A5 publication Critical patent/JP2019501638A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
    • C12Y306/01—Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
    • C12Y306/01022—NAD+ diphosphatase (3.6.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
    • C12Y603/01005—NAD+ synthase (6.3.1.5)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018523761A 2015-11-13 2016-11-14 ニコチンアミドリボシドの微生物生産 Pending JP2019501638A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562254736P 2015-11-13 2015-11-13
US62/254,736 2015-11-13
PCT/US2016/061905 WO2017083858A2 (en) 2015-11-13 2016-11-14 Microbial production of nicotinamide riboside

Publications (2)

Publication Number Publication Date
JP2019501638A true JP2019501638A (ja) 2019-01-24
JP2019501638A5 JP2019501638A5 (enExample) 2019-12-12

Family

ID=58695578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018523761A Pending JP2019501638A (ja) 2015-11-13 2016-11-14 ニコチンアミドリボシドの微生物生産

Country Status (7)

Country Link
US (1) US10913965B2 (enExample)
EP (1) EP3374492A4 (enExample)
JP (1) JP2019501638A (enExample)
KR (1) KR20180083350A (enExample)
CN (1) CN108473948A (enExample)
BR (1) BR112018009393A8 (enExample)
WO (1) WO2017083858A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021070829A1 (enExample) * 2019-10-11 2021-04-15
US11959116B2 (en) 2021-10-27 2024-04-16 Asahi Kasei Pharma Corporation Method for producing nicotinamide mononucleotide

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10913965B2 (en) * 2015-11-13 2021-02-09 Dsm Ip Assets B.V. Microbial production of nicotamide riboside
US20200255877A1 (en) * 2017-05-18 2020-08-13 Dsm Ip Assets B.V. Microbial production of nicotinamide riboside
KR20250007638A (ko) 2017-09-29 2025-01-14 미쯔비시 케미컬 주식회사 니코틴아미드모노뉴클레오티드의 제조 방법 및 그 방법에 사용하는 형질 전환체
WO2020094828A1 (en) * 2018-11-09 2020-05-14 Wageningen Universiteit Microbial hosts engineered for increased tolerance to temperature shifts
CN113755415B (zh) * 2020-06-04 2024-03-29 苏州华赛生物工程技术有限公司 一种新的具有nmn合成路径的重组微生物及生产方法
CN112359082B (zh) * 2020-11-13 2023-02-21 南京工业大学 一种烟酰胺单核苷酸的制备方法
CN112501193B (zh) * 2020-12-09 2022-09-27 江南大学 一种烟酸及烟酰胺生物传感系统
CN112795582B (zh) * 2021-01-22 2022-12-13 江南大学 一种适合在微生物中高效合成nad衍生物的酶基因
CN112852678B (zh) * 2021-03-08 2021-11-05 泓博元生命科技（深圳）有限公司 一株产烟酰胺单核苷酸的成都肠杆菌及其应用
CN112980906B (zh) * 2021-04-14 2021-07-30 深圳瑞德林生物技术有限公司 一种用于制备β-烟酰胺单核苷酸的酶组合物及其应用
CN112795606B (zh) * 2021-04-14 2021-07-27 深圳瑞德林生物技术有限公司 一种β-烟酰胺单核苷酸的酶催化合成方法
CN113528562B (zh) * 2021-06-23 2022-08-16 苏州华赛生物工程技术有限公司 生产β-烟酰胺核糖的重组微生物及其构建方法和应用
CN113897382B (zh) * 2021-09-01 2023-10-20 浙江工业大学 辅酶自足型大肠杆菌及其构建方法与应用
CN114231477B (zh) * 2021-12-27 2024-03-15 天津科技大学 高产β-烟酰胺单核苷酸的基因工程菌株及其构建与应用
CN114854656B (zh) * 2022-05-05 2023-07-18 江南大学 一种产烟酰胺核糖苷的重组菌
CN116286725B (zh) * 2023-03-23 2025-12-12 赛诺根生物科学有限公司 一种催化性能提高的nadh焦磷酸酶突变体及其应用
CN118773286B (zh) * 2024-09-10 2025-02-14 中国科学院深圳先进技术研究院 用于检测qprt活性的组合物、qprt活性的检测方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090202680A1 (en) * 2004-02-10 2009-08-13 Charles Brenner Yeast strain and method for using the same to produce nicotinamide riboside

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102154339A (zh) * 2011-02-16 2011-08-17 南京工业大学 一种产丁二酸大肠杆菌基因工程菌株的构建方法
US20160287621A1 (en) * 2013-11-06 2016-10-06 President And Fellows Of Harvard College Biological production of nad precursors and analogs
US10913965B2 (en) * 2015-11-13 2021-02-09 Dsm Ip Assets B.V. Microbial production of nicotamide riboside

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090202680A1 (en) * 2004-02-10 2009-08-13 Charles Brenner Yeast strain and method for using the same to produce nicotinamide riboside

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
APPL ENVIRON MICROBIOL, 2011 SEP, VOL. 77, NO. 17, PP. 6133-6140, JPN6020040165, ISSN: 0004592978 *
MICROBIOL MOL BIOL REV, 2009 SEP, VOL. 73, NO. 3, PP. 529-541, JPN6020040171, ISSN: 0004371708 *
PROC NATL ACAD SCI U S A, 2009 MAR 3, VOL. 106, NO. 9, PP. 3083-3088, JPN6020040167, ISSN: 0004592979 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021070829A1 (enExample) * 2019-10-11 2021-04-15
WO2021070829A1 (ja) * 2019-10-11 2021-04-15 国立大学法人静岡大学 ニコチンアミドリボシドを産生する乳酸菌、並びにニコチンアミドモノヌクレオチド及びニコチンアミドリボシドを産生する乳酸菌
JP7684906B2 (ja) 2019-10-11 2025-05-28 国立大学法人静岡大学 ニコチンアミドリボシドを産生する乳酸菌、並びにニコチンアミドモノヌクレオチド及びニコチンアミドリボシドを産生する乳酸菌
US11959116B2 (en) 2021-10-27 2024-04-16 Asahi Kasei Pharma Corporation Method for producing nicotinamide mononucleotide

Also Published As

Publication number Publication date
US10913965B2 (en) 2021-02-09
WO2017083858A2 (en) 2017-05-18
EP3374492A4 (en) 2019-07-24
WO2017083858A3 (en) 2017-06-29
EP3374492A2 (en) 2018-09-19
CN108473948A (zh) 2018-08-31
KR20180083350A (ko) 2018-07-20
BR112018009393A2 (pt) 2018-11-13
US20180327797A1 (en) 2018-11-15
BR112018009393A8 (pt) 2019-02-26

Similar Documents

Publication Publication Date Title
US10913965B2 (en) Microbial production of nicotamide riboside
US20190071680A1 (en) Microbial production of nicotinic acid riboside
US20200362381A1 (en) Microbial production of nicotinamide riboside
Chinen et al. Innovative metabolic pathway design for efficient l-glutamate production by suppressing CO2 emission
DK2239336T3 (en) Microorganism for Preparation of L-Amino Acids and Process for Preparation of L-Amino Acids Using the Same
RU2667425C2 (ru) Микроорганизм Corynebacterium sp. с повышенной способностью продуцировать L-лизин и способ получения L-лизина с его помощью
JP7497348B2 (ja) リボフラビンの改善された産生
US20200255877A1 (en) Microbial production of nicotinamide riboside
Heuser et al. Enhancement of the NAD (P)(H) pool in Escherichia coli for biotransformation
US20240043894A1 (en) Production of nmn and its derivatives via microbial processes
US20130210097A1 (en) Glycolic acid fermentative production with a modified microorganism
KR101285945B1 (ko) Ｌ-라이신 생산능이 향상된 코리네박테리움 속 미생물 및 이를 이용한 ｌ-라이신의 제조방법
US20150037850A1 (en) Recombinant microorganism producing quinolinic acid and a method for producing quinolinic acid using the same
JP5230447B2 (ja) 新規方法
DK2430152T3 (en) A microorganism with increased L-lysine productivity and method for producing L-lysine using the same
WO2017158132A1 (en) Microbial production of nicotinic acid riboside
US8859244B2 (en) Method of L-lysine production
KR101429815B1 (ko) ＧｎｔＫ 활성 조절을 통해 Ｌ-쓰레오닌 생산능이 향상된 코리네박테리움 속 미생물 및 이를 이용한 Ｌ-쓰레오닌 생산 방법
JP6697525B2 (ja) キノリン酸を生産する組み換え微生物、及びそれを利用したキノリン酸の生産方法
US20260022411A1 (en) Microbial cell factories producing thiamine
US20240368659A1 (en) Microbial cell factories producing vitamin b compounds
CN117897476A (zh) 生产维生素b化合物的微生物细胞工厂
Deguchi Physiological and biochemical studies on microbial 2´-deoxyribonucleotide biosynthesis and oxidative pyrimidine metabolism
KR100859088B1 (ko) Ｌ-쓰레오닌 생산 변이주 및 이를 이용한 ｌ-쓰레오닌생산 방법
KR20240086806A (ko) 퓨린 뉴클레오티드를 생산하는 미생물 및 이를 이용한 퓨린 뉴클레오티드의 생산방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191101

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191101

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201027

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210326

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210427

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210914